QUANTIPLEX
LIVE

Serial Number

79124568

Owner

QIAGEN GMBH

Attorney

Victoria Friedman

Filing Date

Dec 12, 2012

Add to watchlist:

No watchlists yet
View on USPTO

QUANTIPLEX Trademark

Serial Number: 79124568 • Registration: 4405272

QUANTIPLEX is a trademark filed by QIAGEN GMBH on December 12, 2012. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

QIAGEN GMBH (211 trademarks)

HILDEN D-4010 , DE

Entity Type: 03

Trademark Details

Filing Date

December 12, 2012

Registration Date

September 24, 2013

Published for Opposition

July 9, 2013

Goods & Services

[ Diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; preparations for medical and veterinary purposes, namely, diagnostic preparations for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating and analyzing biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances, namely, reagents, enzymes and buffer solutions for nucleic acid amplification by polymerase chain reaction (PCR); chemical, biochemical and biotechnological preparations, namely, reagents, enzymes and buffer solutions for sample preparation, modification and manipulation of cells and for conducting marking, separating, isolating, purifying, duplicating and analyzing biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances for diagnostic medical and clinical use, namely, reagents, enzymes and buffer solutions for nucleic acid amplification by polymerase chain reaction (PCR); ] kits containing [ preparations for medical and veterinary diagnostic purposes, in particular for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating and analyzing biopolymers in the nature of nucleic acids from biological or ] biochemical sample material for nucleic acid amplification by polymerase chain reaction (PCR)

Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, [ diagnostic preparations except for human or veterinary medical purposes, namely, nonmedical ] reagents, enzymes and buffer solutions for [ scientific and medical research use for sample preparation, modification and manipulation of cells and for conducting marking, separating, isolating, purifying, duplicating and analyzing biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances, namely, reagents, enzymes and buffer solutions for ] nucleic acid amplification by polymerase chain reaction (PCR) [ ; kits comprising chemicals for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating and analyzing biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances, namely, nucleic acids of biological or biochemical sample material comprising chemicals for reagents, enzymes and buffer solutions for nucleic acid amplification by polymerase chain reaction (PCR) ]

Filing History

PARTIAL INVALIDATION PROCESSED BY THE IB
May 3, 2025 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Apr 14, 2025 INPS
INVALIDATION PROCESSED
Apr 14, 2025 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 1, 2025 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jun 1, 2024 NA71
REGISTERED-SEC.71 ACCEPTED
Jun 1, 2024 71AG
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
May 28, 2024 EROP
POST REGISTRATION ACTION MAILED - SEC.71
May 13, 2024 PR71
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 5, 2024 APRE
TEAS SECTION 71 RECEIVED
Sep 5, 2023 ES71
INTERNATIONAL REGISTRATION RENEWED
Dec 30, 2022 RNWL
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Sep 24, 2022 REM4
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Aug 27, 2019 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Aug 27, 2019 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 26, 2019 APRE
TEAS SECTION 71 & 15 RECEIVED
Jul 31, 2019 ES75
NEW REPRESENTATIVE AT IB RECEIVED
Oct 18, 2018 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sep 24, 2018 REM3
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 29, 2014 TCCA
NEW REPRESENTATIVE AT IB RECEIVED
Aug 22, 2014 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 25, 2014 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 9, 2014 FICS
FINAL DISPOSITION PROCESSED
Jan 9, 2014 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 24, 2013 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 24, 2013 R.PR
NOTIFICATION PROCESSED BY IB
Jul 22, 2013 GPNX
NEW REPRESENTATIVE AT IB RECEIVED
Jul 12, 2013 NREP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 9, 2013 NPUB
PUBLISHED FOR OPPOSITION
Jul 9, 2013 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 19, 2013 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 19, 2013 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 19, 2013 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 3, 2013 PREV
ASSIGNED TO LIE
May 31, 2013 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 16, 2013 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 11, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 10, 2013 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 10, 2013 TROA
REFUSAL PROCESSED BY IB
Apr 16, 2013 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 25, 2013 RFCS
REFUSAL PROCESSED BY MPU
Mar 25, 2013 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 23, 2013 RFCR
NON-FINAL ACTION WRITTEN
Mar 22, 2013 CNRT
ASSIGNED TO EXAMINER
Mar 15, 2013 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 15, 2013 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 11, 2013 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 9, 2013 REPR